Want to see ACAN full AI Analyst Report?
ACAN Stock Chart & Stats
$0.02
<$0.01(10.71%)
At close: 4:00 PM EST
$0.02
<$0.01(10.71%)
Day’s Range― - ―
52-Week Range$0.01 - $0.09
Previous CloseN/A
Volume4.82K
Average Volume (3M)63.76K
Market Cap
$2.44K
Enterprise Value$9.24M
Total Cash (Recent Filing)$131.16K
Total Debt (Recent Filing)$6.79M
Price to Earnings (P/E)―
Beta12.77
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding24,391,960
10 Day Avg. Volume71,517
30 Day Avg. Volume63,758
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.18
Price to Sales (P/S)0.64
P/FCF Ratio-0.70
Enterprise Value/Market Cap3.79K
Enterprise Value/Revenue7.25
Enterprise Value/Gross Profit8.11
Enterprise Value/Ebitda-6.92
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Sustainable PracticesAmeriCann's focus on sustainable practices in cannabis cultivation positions it well in an industry increasingly valuing environmental responsibility, potentially attracting eco-conscious tenants and partners.
Strategic PartnershipsStrategic partnerships and additional services like consulting and facility management can enhance tenant operations, increase revenue streams, and strengthen AmeriCann's market position.
High Gross Profit MarginA high gross profit margin indicates strong pricing power and operational efficiency at the core level, providing a foundation for potential profitability improvements if operational inefficiencies are addressed.
Bears Say
Negative Cash FlowsNegative cash flows suggest operational inefficiencies and potential liquidity issues, which can impede the company's ability to fund operations and invest in future growth.
High LeverageHigh leverage increases financial risk, potentially limiting the company's ability to invest in growth opportunities and weather economic downturns, impacting long-term sustainability.
Declining RevenueDeclining revenue trends undermine financial stability and growth prospects, indicating challenges in maintaining market share and competitiveness in the cannabis industry.
AmeriCann News
ACAN FAQ
What was AmeriCann Inc’s price range in the past 12 months?
AmeriCann Inc lowest stock price was $0.01 and its highest was $0.09 in the past 12 months.
What is AmeriCann Inc’s market cap?
AmeriCann Inc’s market cap is $2.44K.
When is AmeriCann Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were AmeriCann Inc’s earnings last quarter?
Currently, no data Available
Is AmeriCann Inc overvalued?
According to Wall Street analysts AmeriCann Inc’s price is currently Overvalued.
Does AmeriCann Inc pay dividends?
AmeriCann Inc does not currently pay dividends.
What is AmeriCann Inc’s EPS estimate?
AmeriCann Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AmeriCann Inc have?
AmeriCann Inc has 24,391,960 shares outstanding.
What happened to AmeriCann Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of AmeriCann Inc?
Currently, no hedge funds are holding shares in ACAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AmeriCann Inc
AmeriCann, Inc., with its headquarters in Denver, Colorado, functions as a specialized cannabis enterprise throughout the United States. The company offers a complete range of services to authorized cannabis businesses, handling the conception, construction, leasing, and daily management of facilities crucial for cultivating, processing, and manufacturing cannabis products. A significant venture for the firm is the Massachusetts Cannabis Center, an extensive development located on a 52-acre property in Freetown, southeastern Massachusetts. Furthermore, AmeriCann supplies cannabis for both medical applications and adult recreational consumption. Incorporated in 2010, the organization initially operated as Nevada Health Scan, Inc., eventually rebranding to AmeriCann, Inc. in 2014.
Gyrodyne Company Of America
―
Maui Land & Pineapple Company
―
New Concept Energy
―
Star Holdings
―
La Rosa Holdings Corp.
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.43% Other Institutional Investors
99.57% Public Companies and
Individual Investors